Why the study?
Real-world evidence integrating clinical outcomes and patient-reported measures in heart failure with reduced ejection fraction remains scarce in middle-income countries.
Does guideline-directed medical therapy (GDMT) improve clinical outcomes and patient-reported quality of life (QoL) in patients with HFrEF?
Does guideline-directed medical therapy (GDMT) improve clinical outcomes and patient-reported quality of life (QoL) in patients with HFrEF?
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: